Stay updated with breaking news from டேவிட் பிரதான. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Share this article Share this article VANCOUVER, BC, Jan. 25, 2021 /PRNewswire/ Notch Therapeutics Inc., a biotechnology company developing renewable stem cell-derived T cell therapies for cancer and other immune disorders, announced today the appointment of Chris Bond, Ph.D. as Senior Vice President, Preclinical and Translational Sciences. Dr. Bond joins Notch from Kite, where he most recently served as Vice President of Cellular Engineering. We are excited to welcome Chris, a highly regarded drug developer and team builder who brings to Notch great depth of experience and expertise in development of cell therapies, gene editing, and cell engineering spanning discovery through IND, said David Main, President and Chief Executive Officer of Notch. Adding Chris to our leadership team will bolster our preclinical pipeline and translational research capabilities to accelerate development of the company s cell therapy candidates from discovery into clinical applicatio ....
«Комсомольская правда» наградила победителей конкурса детского рисунка «Моя любимая мама» rostov.kp.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rostov.kp.ru Daily Mail and Mail on Sunday newspapers.